Seaport Therapeutics Inc. Common Stock

SPTX | NASDAQ

$19.60

-$1.50 (-7.11%)

At close: Oct 30, 2026, 4:00 PM ET

$19.60

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 8:24 AM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
Cash & Equivalents	64.22M	52.91M
Short-Term Investments	209.09M	129.7M
Long-Term Investments	154.21M	30.04M
Other Long-Term Assets	200K	3.84M
Receivables	4.86M	3.28M
Inventory	n/a	n/a
Other Current Assets	n/a	n/a
Total Current Assets	282.18M	188.34M
Property-Plant & Equipment	5.1M	5.45M
Goodwill & Intangibles	n/a	n/a
Total Long-Term Assets	159.51M	39.33M
Total Assets	441.68M	227.67M
Account Payables	5.71M	4.79M
Deferred Revenue	n/a	n/a
Short-Term Debt	1.61M	n/a
Other Current Liabilities	5.29M	1.71M
Total Current Liabilities	15.67M	14.22M
Long-Term Debt	n/a	n/a
Other Long-Term Liabilities	n/a	325.33M
Total Long-Term Liabilities	3.41M	329.07M
Total Liabilities	19.08M	343.29M
Total Debt	5.02M	5.34M
Book Value	422.6M	-115.62M
Book Value Per Share	7.89	-2.18
Common Stock	5K	1K
Retained Earnings	-202.12M	-139.52M
Comprehensive Income	-475K	64K
Shareholders Equity	422.6M	-115.62M
Total Investments	363.29M	159.73M